You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 127 No. 11, November 2001 TABLE OF CONTENTS
  Archives
  •  Online Features
  Original Article
 This Article
 •Full text
 •PDF
 • Reply to article
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citing articles on HighWire
 •Citing articles on ISI (16)
 •Contact me when this article is cited
 Related Content
 •Related article
 •Similar articles in this journal
 Topic Collections
 •General Rhinology
 •Alert me on articles by topic

Surgical Management of Choanal Atresia

Improved Outcome Using Mitomycin

Bradford W. Holland, MD; William F. McGuirt, Jr, MD

Arch Otolaryngol Head Neck Surg. 2001;127:1375-1380.

Objective  To evaluate the intraoperative use of mitomycin to improve the surgical outcome and reduce the rate of soft tissue restenosis in children undergoing choanal atresia repair.

Design  Retrospective chart review of all patients surgically treated for congenital choanal atresia by the senior author (W.F.M).

Setting  Tertiary children's hospital.

Patients  Eight consecutive patients with bony choanal atresia (6 unilateral and 2 bilateral) were compared with 15 historical controls (6 unilateral and 9 bilateral). All study and historical control patients were treated with soft plastic postoperative stenting.

Intervention  At the completion of the surgical repair of the choanal atresia, 0.4 mg/mL of topical mitomycin was applied to the posterior choanae for 3 minutes.

Main Outcome Measure  The success rate of the repair of the choanal atresia as determined by the postoperative need for dilation or revision surgical procedures was compared with that of the historical controls.

Results  All 8 children with intraoperative use of mitomycin were treated with a mean ± SEM of 0.375 ± 0.183 dilations per patient. The 15 children in the control group received a mean ± SEM of 3.667 ± 0.583 postoperative dilations for soft tissue restenosis. The difference in the number of postoperative dilations between the study and control group was statistically significant (P = .006) using a t test.

Conclusions  Mitomycin is an effective and reliable treatment for improving the surgical outcome for choanal atresia repair. This may obviate the need for postoperative dilations and may potentially eliminate the need for surgical stenting.


From the Department of Otolaryngology, Wake Forest University School of Medicine, Brenner Children's Hospital, Winston-Salem, NC.


RELATED ARTICLE

Archives of Otolaryngology–Head & Neck Surgery Reader's Choice: Continuing Medical Education
Arch Otolaryngol Head Neck Surg. 2001;127(11):1403-1405.
FULL TEXT  


THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Single-Stage Choanal Atresia Repair in the Neonate
Zuckerman et al.
Arch Otolaryngol Head Neck Surg 2008;134:1090-1093.
ABSTRACT | FULL TEXT  

Topical Mitomycin C in the Prevention of Keloid Scar Recurrence
Sanders et al.
Arch Facial Plast Surg 2005;7:172-175.
ABSTRACT | FULL TEXT  





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 2001 American Medical Association. All Rights Reserved.